Patients with type 2 diabetes have higher plasma YKL-40 levels compared to subjects with normal glucose tolerance [9,129,130], and plasma YKL-40 is related to insulin resistance [129], fasting plasma glucose, and plasma IL-6 [130], but not to serum CRP [129] or obesity [130]. Here, CHI3L1 is linked to obesity disorder.